Abstract:Epigenetic modifications, such as histone post-translational modifications, DNA methylation, and alteration of gene expression by non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are heritable changes that are independent from the genomic DNA sequence. These regulate gene activities and, therefore, cellular functions. Epigenetic modifications act in concert with transcription factors and play critical roles in B cell development and differentiation, thereby modulating antibody responses to foreign- and self-antigens. Upon antigen encounter by mature B cells in the periphery, alterations of these lymphocytes epigenetic landscape are induced by the same stimuli that drive the antibody response. Such alterations instruct B cells to undergo immunoglobulin (Ig) class switch DNA recombination (CSR) and somatic hypermutation (SHM), as well as differentiation to memory B cells or long-lived plasma cells for the immune memory. Inducible histone modifications, together with DNA methylation and miRNAs modulate the transcriptome, particularly the expression of activation-induced cytidine deaminase, which is essential for CSR and SHM, and factors central to plasma cell differentiation, such as B lymphocyte-induced maturation protein-1. These inducible B cell-intrinsic epigenetic marks guide the maturation of antibody responses. Combinatorial histone modifications also function as histone codes to target CSR and, possibly, SHM machinery to the Ig loci by recruiting specific adaptors that can stabilize CSR/SHM factors. In addition, lncRNAs, such as recently reported lncRNA-CSR and an lncRNA generated through transcription of the S region that form G-quadruplex structures, are also important for CSR targeting. Epigenetic dysregulation in B cells, including the aberrant expression of non-coding RNAs and alterations of histone modifications and DNA methylation, can result in aberrant antibody responses to foreign antigens, such as those on microbial pathogens, and generation of pathogenic autoantibodies, IgE in allergic reactions, as well as B cell neoplasia. Epigenetic marks would be attractive targets for new therapeutics for autoimmune and allergic diseases, and B cell malignancies.

Dysregulated translational factors and epigenetic regulations orchestrate in B cells contributing to autoimmune diseases

Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity

Epigenetic Regulation of B Cells and Its Role in Autoimmune Pathogenesis

The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.

B Cell Activation and Autoantibody Production in Autoimmune Diseases.

Regulatory B cells in autoimmune diseases

Regulatory B Cells and Autoimmune Diseases

Epigenetic Dynamics in Immunity and Autoimmunity

The Critical Importance of Epigenetics in Autoimmunity

The critical role of epigenetics in systemic lupus erythematosus and autoimmunity

Regulatory B cells in autoimmune diseases and mucosal immune homeostasis

Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response

B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases

B Cell Metabolism in Autoimmune Diseases: Signaling Pathways and Interventions

Methylation of T and B Lymphocytes in Autoimmune Rheumatic Diseases

Lipid Metabolism in regulation of B cell development and autoimmunity

Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases

Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review.

Epigenetics as biomarkers in autoimmune diseases.

The critical importance of epigenetics in autoimmune-related skin diseases

Insights into the Role of DNA Methylation in Immune Cell Development and Autoimmune Disease